-
1
Asthma is a chronic inflammatory airway disease characterized by immune activation, airway hyperresponsiveness, and structural remodeling.
-
2
The airway epithelium orchestrates immune responses and drives structural changes through various signaling pathways upon allergen exposure.
-
3
Asthma exhibits immunological heterogeneity, with T2-high eosinophilic and T2-low neutrophilic or mixed endotypes influencing treatment responses.
-
4
The airway epithelium is an active regulator of immune responses, exhibiting intrinsic abnormalities that lower the threshold for allergen-induced inflammation.
-
5
Integrated epithelial signaling networks, rather than single-pathway models, are crucial for understanding asthma pathogenesis and treatment challenges.